Alchemia Cancer drug wins US patent

Company News

Queensland based drug company Alchemia Ltd (ASX:ACL) has won a US patent for a cancer fighting drug it has developed. 

The company says several other countries including Australia and China have secured the patent for the colorectal Cancer treating drug. 

Clinical trials are currently being conducted on more than 400 patients, in 76 different sites around the world.

To December 31st, Alchemia recorded a $5.9 million net loss. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.